MC
HIMS icon

Metavasi Capital’s Hims & Hers Health HIMS Stock Holding History

Metavasi Capital’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.9M Buy
546,429
+324,429
+146% +$8.71M 6.61% 4
2026
Q1 		$4.61M Buy
+222,000
New +$5.24M 1.67% 18
2025
Q4 		– Sell
-166,409
Closed -$9.44M – 31
2025
Q3 		$9.44M Sell
166,409
-20,000
-11% -$1.02M 2.85% 14
2025
Q2 		$9.29M Sell
186,409
-7,559
-4% -$342K 3.79% 9
2025
Q1 		$5.73M Buy
193,968
+6,545
+3% +$243K 3.64% 9
2024
Q4 		$4.53M Sell
187,423
-247,000
-57% -$6.12M 1.6% 20
2024
Q3 		$8M Sell
434,423
-70,577
-14% -$1.26M 3.64% 12
2024
Q2 		$10.2M Buy
+505,000
New +$8.4M 5.35% 3
2023
Q3 		– Sell
-560,000
Closed -$5.26M – 34
2023
Q2 		$5.26M Buy
+560,000
New +$5.55M 3.43% 12

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Metavasi Capital's HIMS Position: Q2 2026 in Review

Metavasi Capital increased its Hims & Hers Health (HIMS) stake by 146% in Q2 2026, buying an estimated $8.71M and bringing the position to 546,429 shares worth $18.9M. The position accounts for 6.61% of the portfolio, ranked #4.

Metavasi Capital first reported a position in HIMS in Q2 2023 and has held it in 9 quarters since. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Metavasi Capital held 546,429 shares of Hims & Hers Health worth $18.9M as of Q2 2026.
  • Metavasi Capital bought 324,429 Hims & Hers Health shares in Q2 2026, an estimated $8.71M.
  • Hims & Hers Health made up 6.61% of Metavasi Capital's portfolio in Q2 2026, its #4 holding.
  • Metavasi Capital first reported a position in Hims & Hers Health in Q2 2023 and has held it in 9 quarters since.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Metavasi Capital's 13F filing for Q2 2026, filed 14 Aug 2026.